|
Real-time Estimate
Cboe BZX
01:03:17 01/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 198.69 USD | -0.17% |
|
-3.31% | +8.74% |
| 12:22am | Axsome Therapeutics Initiates SUMMIT Phase 3 Trial Of AXS-05 In Smoking Cessation | CI |
| 09:36pm | Axsome Therapeutics Starts Phase 3 Trial of AXS-05 for Smoking Cessation | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXSOME THERAPEUTICS, INC. | Biopharmaceuticals | -0.21% | -3.31% | +8.74% | +60.85% | +673.38% | 10.42B |  |  | |
- Stock Market
- Stocks
- AXSM Stock
- Charts Axsome Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
